Reliance Infrastructure faces arbitral award of ₹494 crore in EPC dispute
Sat, Dec 21, 2024 5:04 PM

Reliance Infrastructure faces arbitral award of ₹494 crore in EPC dispute

A Flip by Avya Verma
Get it on Google Play
Anil Ambani's flagship firm Reliance Infrastructure Ltd on Friday (December 20) said it has been ordered to pay ₹494 crore, along with interest, following an arbitral award passed on December 18, 2024, in a dispute with Aravali Power Company Private Ltd (APCPL) over an EPC contract. "..it is hereby informed that today the company is in receipt of an arbitral award dated December 18, 2024.

More great flips

DIIs net bought shares worth Rs 2,174 crore, FIIs net sold Rs 1,893 crore

DIIs net bought shares worth Rs 2,174 crore, FIIs net sold Rs 1,893 crore

On December 30, domestic institutional investors (DIIs) net bought shares worth Rs 2,174 crore crore, while foreign institutional investors (FIIs) net sold shares worth Rs 1,893 crore, provisional data from NSE showed. During the trading session, DIIs bought Rs 41,787 crore and sold shares worth Rs 39,613 crore, and FIIs purchased Rs 15,508 crore in shares.

Open Flip
Govt to adopt new approach to track cost overruns: Sources

Govt to adopt new approach to track cost overruns: Sources

The Indian government will launch a new system in January 2025 to track cost overruns in projects, making the process more standardised, with reforms to the Online Computerised Monitoring System and integration with other government initiatives. The move aims to better track outcomes and address cost overruns, which currently stand at nearly 20% of the original cost.

Open Flip
Lupin acquires Huminsulin from Eli Lilly to enhance diabetes care portfolio

Lupin acquires Huminsulin from Eli Lilly to enhance diabetes care portfolio

Pharma major Lupin has acquired Huminsulin brand in India from Eli Lilly, in an effort to enhance its diabetes portfolio, the company said in an exchange filing on December 30.Lupin had been marketing Huminsulin through an existing agreement with Lilly India before proceeding to acquire the brand. The drug is used in the treatment of Type 1 and Type 2 diabetes mellitus.

Open Flip

Join our Smart Investment Community

More than 2 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon